Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Cell Death Differ ; 15(4): 708-17, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18202705

RESUMO

Human GraB (hGraB) preferentially induces apoptosis via Bcl-2-regulated mitochondrial damage but can also directly cleave caspases and caspase substrates in cell-free systems. How hGraB kills cells when it is delivered by cytotoxic lymphocytes (CL) and the contribution of hGraB to CL-induced death is still not clear. We show that primary human natural killer (hNK) cells, which specifically used hGraB to induce target cell death, were able to induce apoptosis of cells whose mitochondria were protected by Bcl-2. Purified hGraB also induced apoptosis of Bcl-2-overexpressing targets but only when delivered at 5- to 10-fold the concentration required to kill cells expressing endogenous Bcl-2. Caspases were critical in this process as inhibition of caspase activity permitted clonogenic survival of Bcl-2-overexpressing cells treated with hGraB or hNK cells but did not protect cells that only expressed endogenous Bcl-2. Our data therefore show that hGraB triggers caspase activation via mitochondria-dependent and mitochondria-independent mechanisms that are activated in a hierarchical manner, and that the combined effects of Bcl-2 and direct caspase inhibition can block cell death induced by hGraB and primary hNK cells.


Assuntos
Apoptose , Caspases/metabolismo , Granzimas/metabolismo , Células Matadoras Naturais/enzimologia , Mitocôndrias/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Vesículas Secretórias/enzimologia , Clorometilcetonas de Aminoácidos/farmacologia , Apoptose/efeitos dos fármacos , Inibidores de Caspase , Técnicas de Cultura de Células , Células Cultivadas , Inibidores de Cisteína Proteinase/farmacologia , Dipeptídeos/farmacologia , Ativação Enzimática , Granzimas/antagonistas & inibidores , Granzimas/genética , Células HeLa , Humanos , Células Matadoras Naturais/efeitos dos fármacos , Mitocôndrias/enzimologia , Membranas Mitocondriais/metabolismo , Permeabilidade , Inibidores de Proteases/farmacologia , Proteínas Proto-Oncogênicas c-bcl-2/genética , Vesículas Secretórias/efeitos dos fármacos , Fatores de Tempo , Transfecção , Proteínas Inibidoras de Apoptose Ligadas ao Cromossomo X/metabolismo
2.
Oncogene ; 35(9): 1193-7, 2016 Mar 03.
Artigo em Inglês | MEDLINE | ID: mdl-25982280

RESUMO

Scribble complex proteins maintain apicobasal polarity, regulate cell fate determination and function as tumour suppressors in epithelial tissue. Despite evidence that the function of Scribble is maintained in the lymphocyte lineage, we still understand little about its role as a tumour suppressor in haematological malignancies. Using the Eµ-myc model of Burkitt's lymphoma we investigated the role of Scribble in lymphomagenesis. We found that contrary to its well-documented tumour suppressor role in epithelial tissue, loss of Scribble expression delayed the expansion of peripheral B cells and delayed the onset of Eµ-myc-driven lymphoma. This was despite upregulated ERK phosphorylation levels in Scribble-deficient tumours, which are associated with loss of Scribble expression and the development of more aggressive Burkitt's lymphoma. Interestingly, the developmental stage of lymphoma was unaffected by Scribble expression challenging any role for Scribble in fate determination in the haematopoetic lineage. These data provide evidence for oncogenic properties of Scribble in Myc-driven B-cell lymphomagenesis, reinforcing recent findings that overexpression of a mutant form of Scribble can act as an oncogene in epithelial cells. Our results support the growing appreciation that the tumour regulatory functions of Scribble, and other polarity protein family members, are context dependent.


Assuntos
Linfoma de Burkitt/genética , Linfoma de Células B/genética , Proteínas de Membrana/biossíntese , Oncogenes , Proteínas Supressoras de Tumor/biossíntese , Animais , Apoptose/genética , Linfócitos B/metabolismo , Linfócitos B/patologia , Linfoma de Burkitt/patologia , Linhagem Celular Tumoral , Humanos , Linfoma de Células B/patologia , Proteínas de Membrana/genética , Ativação Transcricional/genética , Proteínas Supressoras de Tumor/genética
4.
Respir Care ; 22(9): 912, 1977 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10314882
5.
Infect Immun ; 68(6): 3337-43, 2000 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10816482

RESUMO

Experiments were performed using the standardized murine model of Helicobacter pylori infection to determine the immunogenicity of H. pylori outer membrane vesicles in immune protection. These vesicles, which are naturally shed from the surface of the bacterium, induce a protective response when administered intragastrically to mice in the presence of cholera holotoxin, despite the absence of the urease enzyme and associated Hsp54 chaperonin. Immunoblotting identified a specific serum immunoglobulin G (IgG) response to an 18-kDa outer membrane protein in a significant number of immunized animals. This commonly expressed, immunodominant protein was subsequently identified as lipoprotein 20 (Lpp20). Hybridoma backpacks secreting an IgG1 subclass monoclonal antibody to Lpp20 were generated in H. pylori-infected mice and were found to significantly reduce bacterial numbers, providing evidence that this surface-exposed antigen is a true vaccine candidate and not merely an antigenic marker for successful, protective immunization.


Assuntos
Antígenos de Bactérias/imunologia , Proteínas da Membrana Bacteriana Externa/imunologia , Vacinas Bacterianas/imunologia , Infecções por Helicobacter/imunologia , Helicobacter pylori/imunologia , Lipoproteínas/imunologia , Animais , Anticorpos Antibacterianos/uso terapêutico , Anticorpos Monoclonais/uso terapêutico , Vacinas Bacterianas/uso terapêutico , Feminino , Infecções por Helicobacter/prevenção & controle , Imunização Passiva , Epitopos Imunodominantes , Camundongos , Camundongos Endogâmicos BALB C , Vacinação
6.
Microbios ; 83(337): 217-28, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-8577260

RESUMO

An association between Mycobacterium paratuberculosis and Crohn's disease is suspected but the evidence remains controversial. Using a one-step DNA extraction procedure with the thermophilic protease PRETAQ and amplification by the polymerase chain reaction, M. paratuberculosis DNA was detected in 22% of patients with Crohn's disease, and in 13% of patients with ulcerative colitis. M. paratuberculosis DNA was not found in any biopsy tissue from control non-inflammatory bowel disease patients. The biopsy tissues in which M. paratuberculosis was detected all came from regions which were inflamed when viewed microscopically. Overall, 7.7% of biopsies from such inflamed areas were positive. This low frequency of detection could be explained on the basis of extremely low abundance of the organism in relation to the area of mucosa sampled, or be consistent with a non-aetiological role for M. paratuberculosis in inflammatory bowel disease.


Assuntos
Doenças Inflamatórias Intestinais/microbiologia , Infecções por Mycobacterium/complicações , Mycobacterium avium subsp. paratuberculosis/fisiologia , Animais , Sequência de Bases , Biópsia , Colite Ulcerativa/microbiologia , Colite Ulcerativa/patologia , Colonoscopia , Doença de Crohn/microbiologia , Doença de Crohn/patologia , DNA Bacteriano/análise , Feminino , Humanos , Doenças Inflamatórias Intestinais/patologia , Dados de Sequência Molecular , Mycobacterium avium subsp. paratuberculosis/genética , Mycobacterium avium subsp. paratuberculosis/isolamento & purificação , Reação em Cadeia da Polimerase , Sensibilidade e Especificidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA